The Netherlands
IBIS Technologies, founded in 1996, is headquartered in The Netherlands and stands as a pioneer in the analytics, biopharma, biotechnology, and medical devices sectors. Their slogan, "World leader in multiplex SPR imaging – a groundbreaking technology for detecting and analyzing biomolecules," encapsulates their core competency.
The company specializes in innovative label-free analytical systems using Surface Plasmon Resonance imaging (SPRi) technology, recognized as the gold standard for accurate kinetic data acquisition. Their flagship product, the IBIS MX96, allows for simultaneous analysis of 96 biomolecular interactions with minimal sample volume, showcasing its efficiency and precision.
By enabling the injection of 96 analytes in series overnight, it produces almost 10,000 sensorgrams, revolutionizing the time-consuming processes of epitope discovery, affinity ranking, and cell interaction studies. The IBIS MX96 is proven and adopted by large pharmaceutical companies, biotech firms, and academic institutions, highlighting its commercial and scientific impact despite no recent investment records.
